Susceptibilities of Candida Species Isolated from the Lower Gastrointestinal Tracts of High-Risk Patients to the New Semisynthetic Echinocandin LY303366 and Other Antifungal Agents | Zendy

George G. Zhanel | Zendy; James A. Karlowsky | Zendy; Sheryl Zelenitsky | Zendy; M Turik | Zendy; Daryl J. Hoban | Zendy

Open Access

Susceptibilities of Candida Species Isolated from the Lower Gastrointestinal Tracts of High-Risk Patients to the New Semisynthetic Echinocandin LY303366 and Other Antifungal Agents

Author(s) -

George G. Zhanel,

James A. Karlowsky,

Sheryl Zelenitsky,

M Turik,

Daryl J. Hoban

Publication year - 1998

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.42.9.2446

Subject(s) - echinocandin , candida glabrata , candida albicans , microbiology and biotechnology , biology , antifungal , fungemia , fungi imperfecti , mycosis , fluconazole , immunology

Fifty-two percent of stool specimens collected from 1,200 high-risk patients were colonized with yeasts, primarily Candida albicans (53. 6%) and Candida glabrata (35.7%). Susceptibilities to all antifungal agents tested, including LY303366, were similar to those reported previously for Candida species isolated from blood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research